Korro Bio (KRRO) Total Liabilities (2018 - 2026)

Korro Bio (KRRO) has reported Total Liabilities for 9 consecutive years, with $60.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 7.81% year-over-year to $60.2 million; the trailing twelve-month figure through Jun 2026 stood at $60.2 million (down 7.81% YoY), and the FY2025 full-year result was $62.1 million, down 5.71% from the prior year.
• Total Liabilities slipped to $60.2 million in Q2 2026 per KRRO's latest filing, from $64.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $65.8 million in Q4 2024 and bottomed at $8.9 million in Q4 2022.
• Historically, Total Liabilities has averaged $51.0 million across 5 years, with a median of $53.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities plunged 83.66% in 2022, then soared 564.91% in 2024.
• Over 5 years, Total Liabilities stood at $8.9 million in 2022, then jumped by 480.83% to $51.8 million in 2023, then climbed by 27.19% to $65.8 million in 2024, then decreased by 5.71% to $62.1 million in 2025, then decreased by 2.98% to $60.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $60.2 million, $64.0 million, and $62.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.